MUC16 mutation is associated with tumor grade, clinical features, and prognosis in glioma patients
View ORCID ProfileValéria Pereira Ferrer
doi: https://doi.org/10.1101/2022.02.10.22270821
Valéria Pereira Ferrer
1Laboratory of Cell and Molecular Biology of Tumors, Department of Cell and Molecular Biology, Biology Institute, Fluminense Federal University
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted February 15, 2022.
MUC16 mutation is associated with tumor grade, clinical features, and prognosis in glioma patients
Valéria Pereira Ferrer
medRxiv 2022.02.10.22270821; doi: https://doi.org/10.1101/2022.02.10.22270821
Subject Area
Subject Areas
- Addiction Medicine (373)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2760)
- Dermatology (236)
- Emergency Medicine (414)
- Epidemiology (12413)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4272)
- Geriatric Medicine (396)
- Health Economics (702)
- Health Informatics (2761)
- Health Policy (1021)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (454)
- Neurology (4054)
- Nursing (218)
- Nutrition (600)
- Oncology (2134)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (479)
- Pediatrics (1150)
- Primary Care Research (470)
- Public and Global Health (6663)
- Radiology and Imaging (1453)
- Respiratory Medicine (886)
- Rheumatology (422)
- Sports Medicine (353)
- Surgery (465)
- Toxicology (57)
- Transplantation (192)
- Urology (171)